Mostrando 3 resultados de: 3
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusDifferential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development
ArticleAbstract: Background: Ion channels and transporters are potential markers and therapeutic targets for severalPalabras claves:Diethylnitrosamine, Laser capture microdissection, Liver tumor markers, Multidrug resistance, γ-Glutamyl transferaseAutores:Chávez-lópez M.d.G., Gabiño-López N.B., Hernández-gallegos E., Javier Camacho, Pérez-Carreón J.I., Quintanar-Jurado V., Soriano-Rosas J., Zúñiga-García V.Fuentes:scopusLiver cancer analysis using bioimpedance
Conference ObjectAbstract: In this work the impedance analysis is used in order to determinate differences between tumor and unPalabras claves:Electrical impedance measurement, FFT and cross-correlation, Liver cancer, Phase angleAutores:Chávez-lópez M.d.G., Elías D., Javier Camacho, Salazar-Anguiano J., Zúñiga-García V.Fuentes:scopus